THE COMPANY

CONTEXT AND OBJECTIVE(S)

The French biopharmaceutical group specializes in developing, manufacturing, and marketing plasma-derived medicinal products and recombinant proteins for treating patients with serious and often rare diseases. The company's mission is to provide patients with innovative treatment options to address unmet needs in three major therapeutic areas: immunology, homeostasis, and intensive care.

For its newly developed skin culture technique, the laboratory sought up-to-date and reliable quantitative and qualitative information on burn patients and their treatment in Türkiye.

CONTENT OF SUPPORT

ADVANTIS provided comprehensive market analysis through the following steps :

• Healthcare system and reimbursement analysis :

• Conducted an in-depth examination of the Turkish healthcare system and its reimbursement mechanisms to understand the economic and regulatory landscape.

• Strategic market analysis :

• Engaged in one-on-one conversations with healthcare specialists to gain insights into the primary causes of severe burns, patient demographics, available therapies, and prevalent medical practices in Türkiye.
• In the absence of reliable statistics, reviewed scientific literature to cross-verify figures and ensure the accuracy and currency of the data provided to the company.

• Data synthesis and reporting :

• Compiled and synthesized the information gathered from various sources to create a detailed and actionable report.
• Highlighted key findings, trends, and insights relevant to the company’s new skin culture technique and its potential applications in the Turkish market.
  

RESULT(S)

The comprehensive report enabled the biopharmaceutical group to prioritize its markets for the new skin culture technique and gain a deeper understanding of the overall functioning of the Turkish market, paving the way for the introduction of future solutions.

CASE STUDIES